Non-structural protein 9 (SARS-CoV-2) (nsp9)

SARS-CoV-2 non-structural protein 9 (nsp9) is a highly conserved RNA-binding protein essential for the viral replication and transcription processes [1, 11]. It is cleaved from the large replicase polyproteins (pp1a and pp1ab) by viral proteases and subsequently functions as a key component of the viral replication-transcription complex (RTC) [14, 15]. Nsp9 interacts directly with the NiRAN domain of the RNA-dependent RNA polymerase (nsp12), facilitating processes such as RNA capping and RNAylation, which are vital for the synthesis of functional viral mRNA [7, 8]. Structurally, it forms a homodimer through a conserved GxxxG motif, a configuration traditionally thought to be necessary for efficient nucleic acid binding and overall viral fitness [10, 12]. Beyond its role in replication, nsp9 has been implicated in modulating the host innate immune response, specifically by interacting with TANK-binding kinase 1 (TBK1) to influence cytokine production and potentially interfere with interferon signaling [2, 5, 6]. Due to its indispensable role in the viral life cycle and high conservation across coronaviruses, nsp9 is a significant target for antiviral drug development, with therapeutic strategies aiming to inhibit its RNA-binding capacity, disrupt its dimerization, or block its interaction with the nsp12 polymerase [1, 3, 7].

Other names

nsp9Nonstructural protein 9RNA-binding protein nsp9Replicase polyprotein 1aReplicase polyprotein 1ab

Inhibition of the interaction between nsp9 and nsp12 (RdRp), disruption of nsp9 dimerization, or blocking of its RNA-binding surface to prevent viral replication and transcription.